Abstract
A series of new fluoro S-nitrosothiols is reported as potential nitric oxide (NO) donors. A three-step synthesis and the NO releasing kinetic profiles of these species are presented. The stoichiometric release of NO, with the clean formation of corresponding disulfides, confirms that these new species can facilitate their application as NO donors for various applications including creating novel antimicrobial and thromboresistant fluoropolymer-based medical devices.
Nitric oxide (NO), an endogenous signaling molecule,1–3 has been extensively studied for its vasodilatory,4 antithrombotic,5 immune modulatory,6 antimicriobial,7 anticancer8 and wound healing9 properties. However, due to its high reactivity, the intravascular lifetime of NO is very short (~ 2 s).10 Therefore, precursor molecules (NO donors) are commonly utilized to generate NO in situ for chemical and biochemical studies. So far, various NO donors have been reported,11 including S-nitrosothiols, N-diazeniumdiolates and their derivatives, metal nitrosyls, and N-nitrosamines, as well as organic nitrates and nitrites. Current NO donors are also widely investigated as promising medicinal and therapeutic agents for disease treatments.12–14
Fluorine-containing compounds have significant potential applications in medical and materials chemistry.15, 16 In pharmaceuticals, almost 150 fluorinated drugs have successfully reached the market since the first fluorine-containing drug (fludrocortisone) was approved in 1955.16 Currently, 20% ~ 30% administered drugs contain fluorine atoms or fluoroalkyl groups.16 Fluorocarbon-based materials also have been widely applied in clinical biomaterials,17 affinity chromatography,18 enzyme immobilization,19 crystal engineering20 and supermolecular chemistry.21 Overall, the development of fluorinated compounds and materials with desired functionalities is of continuous interest and has significance in all branches of chemistry.
In the recent development of NO-releasing polymers for use in preparing implanted antimicrobial and thromboresistant biomedical devices (e.g., intravascular catheters, subcutaneous cannula, etc.), chemical leaching of the NO donor and its decomposition products has become a critical concern, owing to possible toxicity issues.22 Very recently, our group reported the incorporation of a novel fluorinated NO donor (S-nitroso-N-pentafluoropropionyl-penicillamine, C2F5-SNAP) into polyvinylidene fluoride for preparation of fluoropolymer-based biomaterials that exhibit NO release and significant antimicrobial properties.23 Due to the specific fluorous-fluorous interactions present between the fluorinated NO donor and the fluoropolymer, leaching of the fluorinated NO donor and the corresponding decomposition products was demonstrated to be quite low (< 10%, total), compared to that observed in the use of non-fluorinated NO donors. Thus, the development of new fluorinated NO donors is of great interest for potentially creating fluoropolymer-based NO release biomaterials from which chemical leaching will be greatly reduced for potential applications of biomedical implants and devices.
To the best of our knowledge, fluorinated S-nitrosothiol type NO donors have not received much attention in the medical and biomaterials research fields. Indeed, to date, only the C2F5-SNAP molecule has been reported as a fluorinated NO donor.23 However, the C2F5-SNAP NO donor was found to be quite unstable even upon storage within a freezer, resulting in the difficulty in handling and storage of this species.23 In contrast, the non-fluorinated S-nitrosoN-acetylpenicillamine (SNAP, see Fig. 1) has great stability, and has extensively been doped into various polymers for the long-term NO release over several months.22 Therefore, there is a need to develop new and relatively stable fluorinated structural analogs of SNAP as NO donors for fluoropolymer-based biomedical devices applications.
Fig. 1.
Chemical structure of SNAP and the design of fluorinated S-nitrosothiols from thiolactone.
Herein, we consider the amine-based nucleophilic addition chemistry of thiolactone (see Fig. 1), which has been widely used to incorporate free thiol moieties as the precursors of S-nitrosothiols.24–27 3-Acetamido-4,4-dimethylthietan-2-one (gem-dimethyl thiolactone) was selected as the thiolactone to imitate the structure of SNAP. To prevent the strong electron withdrawing effects from fluorine or fluoroalkyl groups on the stability of S-N bond, we consider fluorinated benzylamine derivatives as nucleophiles. Specifically, the phenyl ring acts as a linker to diminish the strong electron withdrawing effects from fluoro/trifluoromethyl groups. We hypothesize that a nucleophilic ring opening of the thiolactone in the presence of fluorinated benzylamines should yield amide-based tertiary free thiols, which can be subsequently nitrosylated into fluorinated S-nitrosothiols (see Fig. 1).
In total, 12 fluorinated benzylamines with various degrees of fluorine substitution and 2 non-fluorinated benzylamines were utilized in the synthesis of the new amide-based S-nitrosothiols shown in Scheme 1. The gem-dimethyl thiolactone intermediate was easily obtained from the reaction between D-penicillamine and excess acetic anhydride. In the presence of various benzylamines as nucleophiles, a ring opening of the gem-dimethyl thiolactone yielded amide-based free thiol 2 intermediates. With pure thiol intermediates 2 in hand, a nitrosylation reaction using NaNO2 in presence of strong acid under dark conditions yielded the pure target products 3a-3n as greenish powders. NO donors 3a-3n were obtained with total yields of between 21 % - 30 % in three steps (see Section 2 in SI).
Scheme 1.
Synthesis of NO donors 3a-3n.
Although S-nitrosothiols are known to be relatively unstable due to the inherently weak S-N bond (25 – 31 kcal/mol),28, 29 SNAP is very stable at room temperature. For the previously prepared C2F5-SNAP NO donor, due to the presence of fluorinated groups, C2F5-SNAP was found to be unstable at room temperature and even slowly decompose at - 20 ˚C.23 All new targets 3a-3n were found to be stable during the vacuum drying process at room temperature in the dark. Additionally, they remained stable after being stored at - 20 ˚C over several months. For example, 1H NMR studies of 3l indicated that no decomposition of 3l was observed after storage for 40 days at −20 ˚C under dark conditions (see Fig. S1). Hence, the presence of fluoro/trifluoromethyl groups on the aromatic ring in targets 3a-3n do not appear to decrease the stability of the resulting S-nitrosothiols as was observed for C2F5-SNAP. This result is also consistent with the literature finding that tertiary S-nitrosothiols are known to be thermally stable. 29
To further investigate the NO release profiles from 3a-3n, we carried out kinetic studies of their photolytic and thermal decompositions. For example, the steady-state photolysis of 3k (150 μM) was carried out under 350 nm irradiation in a mixture of PBS and DMSO (50:50, v/v) at 23 ˚C. The UV-Vis spectra of its photodecomposition are shown in Fig. 2a, in which the characteristic UV-Vis band of the nO → π* transition (342 nm) continuously decreases and eventually flattens. The kinetic profile was analyzed using the absorbance changes at 342 nm (Fig. 2a insert), and was fitted to a first-order rate equation giving an observed rate constant kobs = (1.214 ± 0.052)×10−2 s−1 (t1/2 ~ 57 s). The corresponding rate constants and half-lives for the photodecomposition of the other NO donors synthesized in this work are summarized in Table 1. All exhibit first-order decomposition with half-lives between 50 to 80 s under light irradiation. Compared to the photostability of SNAP (t1/2 ~ 46 s), 3a-3n exhibit slower photodecomposition rates. Targets 3m and 3n have similar decomposition rate constants to 3a-3l, indicating that substitution groups on the phenyl ring do not influence the photolytic release rate of NO.
Fig. 2.
(a) UV/Vis spectra for the photolysis of 3k (150 μM) at 23 ˚C in a mixture of PBS and DMSO (50:50, v/v). Inset: Plot of absorbance at 342 nm vs. time and fitting into a first-order rate equation. (b) Plot of absorbance at 342 nm vs. time for the thermal decomposition of 3k (100 μM) at 37 ˚C in a mixture of PBS and DMSO (50:50, v/v).
Table 1.
Kinetic photo-decomposition data for NO donors 1 and 3a–3n under irradiation of 350 nm (4 W) in a mixture of PBS and DMSO (50:50, v/v) at 23 °C.
NO donors | rate constant (s−1) | Half-lives (s) |
---|---|---|
1 (250 μM) | (1.495 ± 0.027)×10−2 | 46 |
3a (250 μM) | (0.945 ± 0.031)×10−2 | 73 |
3b (250 μM) | (1.006 ± 0.023)×10−2 | 69 |
3c (250 μM) | (1.012 ± 0.063)×10−2 | 68 |
3d (250 μM) | (1.384 ± 0.046)×10−2 | 50 |
3e (250 μM) | (1.047 ± 0.050)×10−2 | 66 |
3f (250 μM) | (0.911 ± 0.022)×10−2 | 76 |
3g (250 μM) | (1.009 ± 0.013)×10−2 | 69 |
3h (250 μM) | (0.864 ± 0.017)×10−2 | 80 |
3i (250 μM) | (1.011 ± 0.015)×10−2 | 69 |
3j (150 μM) | (1.191 ± 0.071)×10−2 | 58 |
3k (150 μM) | (1.214 ± 0.052)×10−2 | 57 |
3l (250 μM) | (1.177 ± 0.075)×10−2 | 58 |
3m (250 μM) | (0.972 ± 0.030)×10−2 | 71 |
3n (250 μM) | (1.020 ± 0.034)×10−2 | 68 |
Thermal decomposition studies of 3a-3n at 37 ˚C were also performed in a mixture of PBS and DMSO (50:50, v/v). The absorbance data vs. time for the decomposition of 3k at 342 nm (see Fig. 2b) was monitored and this kinetic data was fitted to a zero-order rate equation, yielding an observed rate constant kobs of (1.446 ± 0.001) × 10−4 μM/min. All of the thermal decomposition kinetic data for compounds 1 and 3a-3n are reported in Table 2. NO donors 3a-3n are less stable in solution when compared to SNAP. NO donors 3d-3e and 3j-3l decomposed via a zero-order reaction model, similar to SNAP. But the others, 3a-3c, 3f-3i and 3m-3n, exhibit first-order decomposition kinetics.
Table 2.
Thermal decomposition kinetic data of NO donors 1 and 3a–3n at 37 °C in a mixture of PBS and DMSO (50:50, v/v).
NO donors | Rate constant | Half-lives (h) |
---|---|---|
1 (100 μM) | (1.586 ± 0.012)×10−5 μM/min | 56.22 |
3a (250 μM) | (2.070 ± 0.027)×10−3 min−1 | 5.58 |
3b (250 μM) | (2.720 ± 0.021)×10−3 min−1 | 4.25 |
3c (250 μM) | (2.480 ± 0.036)×10−3 min−1 | 4.66 |
3d (100 μM) | (8.395 ± 0.028)×10−5 μM/min | 6.45 |
3e (100 μM) | (4.685 ± 0.001)×10−5 μM/min | 15.47 |
3f (250 μM) | (2.290 ± 0.104)×10−3 min−1 | 5.04 |
3g (250 μM) | (2.180 ± 0.082)×10−3 min−1 | 5.30 |
3h (150 μM) | (1.970 ± 0.039)×10−3 min−1 | 5.86 |
3i (250 μM) | (2.130 ± 0.114)×10−3 min−1 | 5.42 |
3j (100 μM) | (1.366 ± 0.011)×10−4 μM/min | 4.70 |
3k (100 μM) | (1.446 ± 0.001)×10−4 μM/min | 5.24 |
3l (100 μM) | (8.089 ± 0.062)×10−5 μM/min | 6.49 |
3m (250 μM) | (2.010 ± 0.090)×10−3 min−1 | 5.75 |
3n (250 μM) | (2.520 ± 0.075)×10−3 min−1 | 4.58 |
To understand these different kinetic behaviors, we also performed computational calculations (see Section 5 in SI). Interestingly, the transition state for the homolysis of the S-N bond resulting in NO release does not exist. We found experimentally that the NO release was mainly determined by the calculated binding dissociation enthalpy (BDE) of S-N bond. Compared to SNAP, 3e, 3l and 3m have slightly lower BDE (see Table 3S) for the S-N bond. Thus, 3e, 3l and 3m are less stable than SNAP, consistent with our kinetic results under the thermal decomposition.
Furthermore, the emitted NO gas released by each new donor was accurately quantitated by an NOA chemiluminescence method. For instance, the photolysis of 3k (1.50 × 10−7 mol) within a NOA reaction cell was conducted in a mixture of PBS and DMSO (50:50, v/v) under 350 nm lamp irradiation, in which the corresponding NO gas signal was monitored by the NOA analyzer (see Fig. 3a). Three independent photolysis reactions gave the average NO generation yield of 98 ± 2 %. These results indicate that NO donor 3k can stoichiometrically release NO.
Fig. 3.
(a) Stoichiometric NO determination observed for photolysis of 3k (1.50 × 10−7 mol) using chemiluminescence NOA detection of emitted NO in a mixture of PBS (10.0 mM, pH 7.40, with 100 μM EDTA) and DMSO (50:50, v/v) at 23 ˚C, and (b) NO release reaction for NO donors 3.
In addition to NO gas, the corresponding disulfide is reported to be the product derived from the decomposition of S-nitrosothiols.30 To further examine the disulfide formation, products derived from both the photo and thermal decomposition of 3k (2.98 mM) in DMSO-d6 were analyzed by 1H NMR spectroscopy (see Fig. 4). Before the decomposition, methide and gem-dimethyl groups in 3k had chemical shifts at ~ 5.30, 1.98 and 1.96 ppm. After photolysis for 2 h, 3k was completely decomposed, to cleanly yield the disulfide, with the methide resonance at ~ 4.65 ppm and gem-dimethyl groups at ~ 1.33 and 1.25 ppm. This disulfide was further confirmed by HRMS results (m/z (ESI): calculated for [M+H]+ = 731.1966; found = 731.1965). Interestingly, a partial thermal decomposition of 3k was observed after 4 d at 37 ˚C in the dark (see Fig. 4), yielding a mixture of 3k and its corresponding disulfide. These data provide evidence that 3k can be employed as a pure NO donor, to stoichiometrically release NO and the corresponding disulfide. The mechanism of NO-release from S-nitrosothiols has been well-studied under heat, irradiation, and Cu+ mediated reduction conditions.28, 30 A homolysis of the weak S-N bond could yield equal moles of NO and a thiyl radical. Thiyl radical intermediates are typically reactive, subsequently resulting in a rapid dimerization to yield the corresponding disulfide.28, 30 Finally, a possible NO generation pathway for NO donors 3 is summarized in Fig. 3b, based on our NO measurement and disulfide characterization.
Fig. 4.
1H NMR spectra for 3k (2.98 mM) before and after decomposition in DMSO-d6 (1) before decomposition, (2) after photolysis at 23 ˚C for 2 h, (3) after thermal decomposition at 37 ˚C in the dark for 4 d.
To summarize, a novel family of fluorinated S-nitrosothiols has been reported herein. The presence of fluorine or fluoroalkyl groups on the benzylamide does not influence the stability of the S-N bond. Kinetic studies of their photolytic and thermal decomposition reactions were conducted. The stoichiometric release of NO and the corresponding disulfide formation from decomposition was monitored by NO chemiluminescence measurements and 1H NMR spectroscopy, respectively. Detailed theoretical calculations on the relationship between structure and stability of these new fluorinated NO donors are currently underway. We anticipate that these new species will have applications as useful NO release agents, potentially for incorporation into fluorinated biopolymers for preventing infection and/or thrombosis on surfaces of various medical devices. Such studies are now ongoing in our laboratory.
Supplementary Material
Acknowledgements
The authors acknowledge the Juvenile Diabetes Research Foundation (JDRF: 2-SRA-2016–230-Q-R) and the National Institutes of Health (HL-128337) for supporting this research. We also are grateful to Dr. Paul Sampson at Kent State University for helpful discussion on fluorine chemistry.
Footnotes
Conflicts of interest
There are no financial conflicts to declare.
† Electronic Supplementary Information (ESI) available: Experimental details. See DOI: 10.1039/x0xx00000x
Notes and references
- 1.Heinrich TA, da Silva RS, Miranda KM, Switzer CH, Wink DA and Fukuto JM, Br. J. Pharmacol, 2013, 169, 1417–1429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Thomas DD, Redox Biol., 2015, 5, 225–233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Farah C, Michel LYM and Balligand J-L, Nat. Rev. Cardiol, 2018, 15, 292. [DOI] [PubMed] [Google Scholar]
- 4.Simmonds MJ, Detterich JA and Connes P, Biorheology, 2014, 51, 121–134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Constantine T and Jane EF, Curr. Drug Targets, 2006, 7, 1243–1251. [DOI] [PubMed] [Google Scholar]
- 6.Bogdan C, Trends Immunol., 2015, 36, 161–178. [DOI] [PubMed] [Google Scholar]
- 7.Yang L, Feura ES, Ahonen MJR and Schoenfisch MH, Adv. Healthc. Mater, 2018, 7, 1800155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Huzefa V, Munawwar Ali K, Usama A and and Arif H, J. Cancer Prev, 2016, 21, 1–12.27051643 [Google Scholar]
- 9.Krausz A and Friedman AJ, Future Sci. OA, 2015, 1, FSO56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Liu X, Miller MJS, Joshi MS, Sadowska-Krowicka H, Clark DA and Lancaster JR, J. Biol. Chem, 1998, 273, 18709–18713. [DOI] [PubMed] [Google Scholar]
- 11.Wang PG, Xian M, Tang X, Wu X, Wen Z, Cai T and Janczuk AJ, Chem. Rev, 2002, 102, 1091–1134. [DOI] [PubMed] [Google Scholar]
- 12.Ostrowski AD and Ford PC, Dalton Trans, 2009, 10660–10669. [DOI] [PubMed] [Google Scholar]
- 13.Huang Z, Fu J and Zhang Y, J. Med. Chem, 2017. [DOI] [PubMed] [Google Scholar]
- 14.Munzel T and Daiber A, Vasc. Pharmacol, 2018, 102, 1–10. [DOI] [PubMed] [Google Scholar]
- 15.Berger R, Resnati G, Metrangolo P, Weber E and Hulliger J, Chem. Soc. Rev, 2011, 40, 3496–3508. [DOI] [PubMed] [Google Scholar]
- 16.Zhou Y, Wang J, Gu Z, Wang S, Zhu W, Aceña JL, Soloshonok VA, Izawa K and Liu H, Chem. Rev, 2016, 116, 422–518. [DOI] [PubMed] [Google Scholar]
- 17.Cardoso V, Correia D, Ribeiro C, Fernandes M and Lanceros-Méndez S, Polymers, 2018, 10, 161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Hayama T, Yoshida H, Yamaguchi M and Nohta H, J. Pharm. Biomed. Anal, 2014, 101, 151–160. [DOI] [PubMed] [Google Scholar]
- 19.Rapp HM, Bacher S, Ahrens A, Rapp W, Kammerer B, Nienhaus GU and Bannwarth W, Chem Plus Chem, 2012, 77, 1066–1070. [Google Scholar]
- 20.Chopra D and Row TNG, Cryst Eng Comm, 2011, 13, 2175–2186. [Google Scholar]
- 21.Omorodion H, Twamley B, Platts JA and Baker RJ, Crystal Growth Des, 2015, 15, 2835–2841. [Google Scholar]
- 22.Wo Y, Brisbois EJ, Bartlett RH and Meyerhoff ME, Biomater. Sci, 2016, 4, 1161–1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Zhou Y, Zhang Q, Wu J, Xi C and Meyerhoff ME, J. Mater. Chem. B, 2018, 6, 6142–6152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Soulère L, Sturm J-C, Núñez-Vergara LJ, Hoffmann P and Périé J, Tetrahedron, 2001, 57, 7173–7180. [Google Scholar]
- 25.Frost MC and Meyerhoff ME, J. Am. Chem. Soc, 2004, 126, 1348–1349. [DOI] [PubMed] [Google Scholar]
- 26.Stasko NA, Fischer TH and Schoenfisch MH, Biomacromolecules, 2008, 9, 834–841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Grommersch BM, Pant J, Hopkins SP, Goudie MJ and Handa H, ACS Appl. Mater. Interfaces, 2018, 10, 2291–2301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Williams DLH, Chem. Comm, 1996, 1085–1091. [Google Scholar]
- 29.Williams DLH, Acc. Chem. Res, 1999, 32, 869–876. [Google Scholar]
- 30.Zhang C, Biggs TD, Devarie-Baez NO, Shuang S, Dong C and Xian M, Chem. Comm, 2017, 53, 11266–11277. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.